J 2020

Results of Ranibizumab Treatment of the Myopic Choroidal Neovascular Membrane according to the Axial Length of the Eye

STEPANOV, Alexandr, Martin PENCAK, Jan NEMCANSKY, Veronika MATUŠKOVÁ, Marketa STREDOVA et. al.

Basic information

Original name

Results of Ranibizumab Treatment of the Myopic Choroidal Neovascular Membrane according to the Axial Length of the Eye

Name in Czech

Výsledky léčby myopických neovaskulárních ranibizumabem s ohledem na délku oka

Authors

STEPANOV, Alexandr (203 Czech Republic, guarantor), Martin PENCAK (203 Czech Republic), Jan NEMCANSKY (203 Czech Republic), Veronika MATUŠKOVÁ (203 Czech Republic, belonging to the institution), Marketa STREDOVA (203 Czech Republic), David BERAN (203 Czech Republic) and Jan STUDNICKA (203 Czech Republic)

Edition

Journal of Ophthalmology, London, Hindawi Publishing Corporation, 2020, 2090-004X

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30207 Ophthalmology

Country of publisher

United Kingdom of Great Britain and Northern Ireland

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 1.909

RIV identification code

RIV/00216224:14110/20:00115863

Organization unit

Faculty of Medicine

UT WoS

000537131400001

Keywords in English

myopic CNV; axial myopia; choroidal neovascular membrane

Tags

Tags

International impact, Reviewed
Změněno: 26/6/2020 12:40, Mgr. Tereza Miškechová

Abstract

V originále

A retrospective evaluation of the results of treatment of myopic choroidal neovascularization (mCNV) with intravitreal injections of ranibizumab in a pro re nata (PRN) regimen in three groups of patients distributed according to axial length.